Acadian Asset Management’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMUX
BI
APM
SCM
RI
OFM
IC
Acadian Asset Management's IMUX Position: Q4 2024 in Review
Acadian Asset Management sold out of Immunic (IMUX) in Q4 2024, closing a stake of 9,655 shares — an estimated $158K sold.
Acadian Asset Management first reported a position in IMUX in Q4 2017 and held it in 11 quarters. The position peaked at $1.5M in Q2 2023. 65 funds tracked by Wall St. Rank hold IMUX as of Q4 2024.
- Acadian Asset Management reported no remaining Immunic position as of Q4 2024 after selling out during the quarter.
- Acadian Asset Management sold 9,655 Immunic shares in Q4 2024, an estimated $158K.
- Acadian Asset Management first reported a position in Immunic in Q4 2017 and held it in 11 quarters.
- Acadian Asset Management's Immunic position peaked at $1.5M in Q2 2023.
- 65 funds tracked by Wall St. Rank held Immunic as of Q4 2024.
Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.